As of 2026-06-30, the Relative Valuation of Lexicon Pharmaceuticals Inc (LXRX) is (1.42) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.64 USD, the upside of Lexicon Pharmaceuticals Inc based on Relative Valuation is -153.9%.
The range of the Relative Valuation is (1.31) - (1.60) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.2x - 20.2x | 17.0x |
| Forward P/E multiples | 16.5x - 20.5x | 18.9x |
| Fair Price | (1.31) - (1.60) | (1.42) |
| Upside | -149.6% - -160.5% | -153.9% |
| Date | P/E |
| 2026-06-26 | -32.18 |
| 2026-06-25 | -28.90 |
| 2026-06-24 | -28.01 |
| 2026-06-23 | -27.26 |
| 2026-06-22 | -27.13 |
| 2026-06-18 | -25.36 |
| 2026-06-17 | -25.74 |
| 2026-06-16 | -24.61 |
| 2026-06-15 | -24.73 |
| 2026-06-12 | -24.23 |
| 2026-06-11 | -23.85 |
| 2026-06-10 | -23.72 |
| 2026-06-09 | -23.72 |
| 2026-06-08 | -23.72 |
| 2026-06-05 | -24.10 |
| 2026-06-04 | -23.98 |
| 2026-06-03 | -23.35 |
| 2026-06-02 | -23.85 |
| 2026-06-01 | -26.12 |
| 2026-05-29 | -27.51 |
| 2026-05-28 | -27.89 |
| 2026-05-27 | -27.38 |
| 2026-05-26 | -26.00 |
| 2026-05-22 | -27.26 |
| 2026-05-21 | -28.14 |
| 2026-05-20 | -27.89 |
| 2026-05-19 | -26.88 |
| 2026-05-18 | -27.00 |
| 2026-05-15 | -28.14 |
| 2026-05-14 | -29.40 |
| 2026-05-13 | -30.79 |
| 2026-05-12 | -30.41 |
| 2026-05-11 | -29.15 |
| 2026-05-08 | -25.24 |
| 2026-05-07 | -21.20 |
| 2026-05-06 | -20.19 |
| 2026-05-05 | -20.82 |
| 2026-05-04 | -20.19 |
| 2026-05-01 | -20.57 |
| 2026-04-30 | -20.32 |
| 2026-04-29 | -19.56 |
| 2026-04-28 | -20.95 |
| 2026-04-27 | -21.33 |
| 2026-04-24 | -21.20 |
| 2026-04-23 | -21.20 |
| 2026-04-22 | -22.97 |
| 2026-04-21 | -23.09 |
| 2026-04-20 | -23.22 |
| 2026-04-17 | -23.60 |
| 2026-04-16 | -23.22 |